Literature DB >> 29589965

Do pre-clinical multiple sclerosis models allow us to measure neurodegeneration and clinical progression?

Tanja Hochstrasser1, Zhan Jiangshan1, Sebastian Rühling1, Christoph Schmitz1, Markus Kipp1.   

Abstract

Entities:  

Keywords:  Brain atrophy; clinical trials; cuprizone; experimental autoimmune encephalomyelitis; neurodegeneration; progressive multiple sclerosis

Year:  2018        PMID： 29589965     DOI： 10.1080/14737175.2018.1459190

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  4 in total

1.  Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.

Authors:  Sebastian Rühling; Franziska Kramer; Selina Schmutz; Sandra Amor; Zhan Jiangshan; Christoph Schmitz; Markus Kipp; Tanja Hochstrasser
Journal:  Mol Neurobiol       Date:  2018-09-21       Impact factor: 5.590

2.  Translational Block in Stroke: A Constructive and "Out-of-the-Box" Reappraisal.

Authors:  Athanasios Lourbopoulos; Iordanis Mourouzis; Christodoulos Xinaris; Nefeli Zerva; Konstantinos Filippakis; Angelos Pavlopoulos; Constantinos Pantos
Journal:  Front Neurosci       Date:  2021-05-14       Impact factor: 4.677

Review 3.  Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2020-07       Impact factor: 5.135

4.  Aquaporin-4 Expression during Toxic and Autoimmune Demyelination.

Authors:  Sven Olaf Rohr; Theresa Greiner; Sarah Joost; Sandra Amor; Paul van der Valk; Christoph Schmitz; Markus Kipp
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.